Proxy advisers inflict 'serious harm' to UK, says AstraZeneca chair - Financial Times
- Proxy advisers inflict 'serious harm' to UK, says AstraZeneca chair Financial Times
- L&G fires warning shot at AstraZeneca over Pascal Soriot pay The Times
- AstraZeneca CEO’s £18.7m pay approved despite shareholder rebellion The Guardian
- Was AstraZeneca boss Soriot's pay rise controversial? Not particularly Proactive Investors UK
- AstraZeneca hit by investor backlash over chief Pascal Soriot's £19m pay deal The Telegraph